Hhlr Advisors, Ltd. Surrozen, Inc. Transaction History

Hhlr Advisors, Ltd.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$0.42 - $41.25 $16,212 - $1.59 Million	-38,600 Reduced 3.22%	1,161,400 $673,000
Q3 2021 Nov 15, 2021	BUY	$6.98 - $12.03 $8.38 Million - $14.4 Million	1,200,000 New	1,200,000 $8.5 Million

4.52M

Ticker SRZN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,122,900
Market Cap $358M
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.